Ex post, all patients fulfilled the revised diagnostic criteria for MS which prompted the search for anti-flotillin-1/2 in a cohort of 538 pre-diagnosed MS patients that revealed another 8 patients bearing the autoantibodies. Here, FLOT1 is linked to myeloid sarcoma.